Profile
Sector:
IndustrialsIndustry:
Specialty Industrial MachineryCountry:
United StatesIPO:
08 May 2008Website:
http://www.enovis.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Tue, 02 Jul 2024 20:02:16 GMTDividend
Analysts recommendations
Institutional Ownership
ENOV Latest News
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Zacks Medical Info Systems industry stocks like Hims & Hers Health (HIMS), Enovis Corporation (ENOV) and Health Catalyst (HCAT) are expected to gain from the GenAI wave.
Enovis (ENOV) is currently considered oversold, suggesting that the intense selling pressure on the stock may be easing. This, along with widespread agreement among Wall Street analysts in raising earnings forecasts, could lead to a potential turnaround for the stock soon.
Enovis (ENOV) reported quarterly earnings of $0.50 per share, matching the Zacks Consensus Estimate. This is an increase from earnings of $0.44 per share in the same quarter last year.
Wilmington, DE, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2023 financial results on Thursday, February 22, 2024 at 8:30AM ET and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.
Enovis' (ENOV) latest buyout is expected to expand its international scale with a complementary global customer base and product mix and improve efficiency with innovative manufacturing facilities.
The mean of analysts' price targets for Enovis (ENOV) points to a 43.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Enovis (ENOV) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.59 per share a year ago.
Enovis (ENOV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Enovis (ENOV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 1(current)
What type of business is Enovis?
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
What sector is Enovis in?
Enovis is in the Industrials sector
What industry is Enovis in?
Enovis is in the Specialty Industrial Machinery industry
What country is Enovis from?
Enovis is headquartered in United States
When did Enovis go public?
Enovis initial public offering (IPO) was on 08 May 2008
What is Enovis website?
https://www.enovis.com
Is Enovis in the S&P 500?
No, Enovis is not included in the S&P 500 index
Is Enovis in the NASDAQ 100?
No, Enovis is not included in the NASDAQ 100 index
Is Enovis in the Dow Jones?
No, Enovis is not included in the Dow Jones index
When does Enovis report earnings?
The next expected earnings date for Enovis is 02 August 2024